In addition, Eli Lilly is developing an AI-assisted individualized dosing model, which dynamically adjusts the dosage based on real-time blood glucose, weight, and liver and kidney functions, further reducing the burden of self-management for patients and making the treatment more precise and convenient
A (retail) home of their own for GLP-1related products Retailers are responding to the GLP-1 revolution by merchandising related products together in a special section
Foods to Avoid When Increasing GLP-1 With higher levels of GLP-1 present in the body, youll want to stray from foods that can spike blood sugar or cause any GI discomfort
While retatrutide Phase 2 data showed improvements in cardiovascular risk markers, individual responses vary, and new cardiac symptoms during any peptide protocol should be evaluated immediately
Bright-field imaging was performed with a white light-emitting diode
The FDA says it has received reports of people overdosing on compounded semaglutide, giving themselves as much as 20 times more than the intended dose of the medication